Introduction
============

Endometriosis is a benign gynecological disorder that occurs in 10% of women of reproductive age ([@b1-etm-0-0-5185]). The main symptoms include infertility and chronic pelvic pain ([@b2-etm-0-0-5185]). Although there are a number of studies on endometriosis, the majority of the mechanisms are not well understood ([@b3-etm-0-0-5185]--[@b6-etm-0-0-5185]). Identifying disease biomarkers and their interaction networks is important to improve the understanding of the causes of endometriosis, as well as to improve medical care.

Several databases have been developed that store associations between genes and diseases, such as the Online Mendelian Inheritance in Man ([@b7-etm-0-0-5185]), the Human Gene Mutation Database ([@b8-etm-0-0-5185]) and the Genetic Association Database ([@b9-etm-0-0-5185]). Due to the nature of the database curation process, the data are incomplete. Some gene-disease databases that combine gene-associated diseases from several expert, public and curated data sources also exist ([@b10-etm-0-0-5185],[@b11-etm-0-0-5185]). With the rapid accumulation of gene-disease data, increasing research has been utilizing the gene-disease database as a start-point to mine disease biomarkers ([@b12-etm-0-0-5185]--[@b14-etm-0-0-5185]).

Protein-protein interaction (PPI) networks include information on the biological processes and molecular functions of cells and have been widely used to characterize the underlying mechanisms of genes associated with complex diseases ([@b15-etm-0-0-5185],[@b16-etm-0-0-5185]). The majority of human diseases are caused by a group of correlated molecules or a network, rather than a single gene ([@b17-etm-0-0-5185]). Thus, identification and validation of biomarker networks is critical to disease diagnosis, prognosis and treatment.

In the present study, a disease network of endometriosis that integrated human PPIs and known disease-causing genes was constructed. Endometriosis-causing genes were identified from gene-disease databases. Subsequently, bioinformatics approaches, including PPI network construction, module analysis, functional enrichment analysis and text mining, were utilized in the research. The results of the present study may provide new targets for endometriosis therapy and identify the potential mechanisms of the disease.

Materials and methods
=====================

### Seed gene selection

Endometriosis-related genes were obtained from Genotator (<http://genotator.hms.harvard.edu/>) ([@b10-etm-0-0-5185]) and DisGeNET (<http://www.disgenet.org>) ([@b11-etm-0-0-5185]). For each tool, gene lists were extracted using the query term, endometriosis. Genotator provides high quality gene-disease associations based upon data from 11 trustworthy resources. DisGeNET is a discovery platform that integrates information on gene-disease associations from several public data sources and literature ([@b11-etm-0-0-5185]). Thus, a list of genes that had been experimentally validated to be associated with endometriosis were obtained.

### Disease-gene network construction

Endometriosis-associated genes were submitted to atBioNet (<https://www.fda.gov/ScienceResearch/BioinformaticsTools/ucm285284.htm>) and PPIs were obtained. atBioNet is a network analysis tool that provides a systematic insight into gene interactions by examining significant functional modules ([@b18-etm-0-0-5185]). The default option is 'Human Database' that combines data from a variety of public PPI sources, including BioGRID ([@b19-etm-0-0-5185]), the Database of Interacting Proteins ([@b20-etm-0-0-5185]), the Human Protein Reference Database ([@b21-etm-0-0-5185]), IntAct ([@b22-etm-0-0-5185]), the Molecular INTeraction database ([@b23-etm-0-0-5185]), REACTOME ([@b24-etm-0-0-5185]) and the Signaling Pathways Integrated Knowledge Engine ([@b25-etm-0-0-5185]). The protein interaction network included 12,043 human proteins and 132,605 interactions. SCAN algorithm was used to identify functional modules and perform assessment of generated gene networks for biomarker discovery ([@b26-etm-0-0-5185]).

### Pathway enrichment analysis

To identify potential roles of genes in endometriosis, the Kyoto Encyclopedia of Genes and Genomes (KEGG) ([@b27-etm-0-0-5185]) pathway analysis component in atBioNet was used. Overrepresented KEGG pathways for each module were ranked according to the P-value obtained from Fisher\'s exact tests.

### Literature mining

To identify the genes associated with endometriosis, mining from the PubMed database (<https://www.ncbi.nlm.nih.gov/pubmed>) with keywords 'gene symbol' and 'endometriosis' was conducted. Subsequently, the articles associated with endometriosis were screened manually. A high number of papers indicated that the relationship between potential biomarker genes and endometriosis is well studied and documented.

Results
=======

### Screening of seed genes related to endometriosis

A total of 271 and 229 genes were extracted from Genotator and DisGeNET, respectively. The common genes, of which there were 100, were used as seed genes to generate functional modules.

### Construction of biomarker networks

Of 100 input genes, 96 were found in GenBank (<https://www.ncbi.nlm.nih.gov/genbank/>), and network clustering identified six major sub network modules from the original PPI network ([Fig. 1](#f1-etm-0-0-5185){ref-type="fig"}). Hub genes in each module were identified ([Table I](#tI-etm-0-0-5185){ref-type="table"}).

### KEGG pathway analysis

A total of 2,429 genes from the KEGG human database were added to the PPI network and genes in each module were selected for pathway enrichment analysis. The top 10 significantly enriched KEGG pathways for the six modules in endometriosis are demonstrated in [Table II](#tII-etm-0-0-5185){ref-type="table"}. Module A was a cancer cell proliferation module. The majority of the pathways in the first module were related to the proliferation of cancer cells and were associated with pathways in cancer, the cell cycle, oocyte meiosis, adherens junctions and the Wnt signaling pathway. The enriched pathways in module B were associated with the immune system and infectious diseases, including cytokine-cytokine receptor interaction, the mitogen-activated protein kinase signaling pathway, the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway, the intestinal immune network for immunoglobulin (Ig) A production and Toll-like receptor signaling pathways. Module C was associated with complement and coagulation cascades, extracellular matrix-receptor interaction, focal adhesion, and proteasome and hematopoietic cell lineages associated with immune and metastasis. The enriched pathways in module D were associated with inflammatory responses, including phagosome, cell adhesion molecules, antigen processing and presentation, natural killer cell mediated cytotoxicity, T cell receptor signaling pathways and the intestinal immune network for IgA production. The majority of the pathways in module E were related to processes of replication and repair, including DNA replication, base excision repair, nucleotide excision repair, mismatch repair and homologous recombination.

### Endometriosis-associated genes identified in literature

A total of 15 genes, seven in the first module and eight in the second module, have previously been reported in literature to be candidate biomarkers for endometriosis ([Fig. 2](#f2-etm-0-0-5185){ref-type="fig"}). For example, women with endometriosis had significantly higher SOX2 expression levels compared to controls ([Fig. 2A](#f2-etm-0-0-5185){ref-type="fig"}) ([@b28-etm-0-0-5185]). Also, various genes identified in the second module ([Fig. 2B](#f2-etm-0-0-5185){ref-type="fig"}), including CASP3, S100A13 and IL1R2, have been reported to be associated with endometriosis ([@b29-etm-0-0-5185]--[@b31-etm-0-0-5185]). Details for the 15 literature-confirmed potential endometriosis biomarkers are listed in [Table III](#tIII-etm-0-0-5185){ref-type="table"}.

Discussion
==========

The cause of endometriosis is not entirely understood. No single theory is able to explain all cases of endometriosis. The present study implemented PPI for endometriosis biomarker network analysis and identified biologically relevant functional modules. A number of genes and pathways identified in the modules have already been reported to participate in the pathogenesis of endometriosis ([@b32-etm-0-0-5185]--[@b36-etm-0-0-5185]).

Although endometriosis is a benign disorder, several common characteristics of this disease are shared with invasive cancer ([@b37-etm-0-0-5185]). Previous epidemiologic studies have demonstrated that women with endometriosis have an increased risk of ovarian and breast cancer ([@b38-etm-0-0-5185],[@b39-etm-0-0-5185]). Coincidentally, the three chromosomal regions (9p, 11q and 22q) that have demonstrated loss of heterozygosity in ovarian endometriosis were the same that were observed in ovarian tumors ([@b40-etm-0-0-5185]). These studies have demonstrated that the inactivation of tumor suppressor genes has an important role in the development of endometriosis. The results of the present study demonstrated that expression of cancer-related pathways are significantly imbalanced in endometriosis in module A. The hub genes identified were AHR, AR, ARNT, ESR1, NRIP1, ESR2, TP53, NR5A1, NR3C1 and PGR.

The enriched pathways in module B were associated with the immune system and infectious diseases. The presence of proinflammatory cytokines in the peritoneal fluid of patients with endometriosis has been reported in previous studies ([@b41-etm-0-0-5185]--[@b43-etm-0-0-5185]). Cytokines may regulate the actions of leukocytes in the peritoneal fluid or may act directly on the ectopic endometrium ([@b44-etm-0-0-5185]). Dysregulation of the JAK-STAT pathway is associated with various immune disorders ([@b45-etm-0-0-5185]), which was also demonstrated in the results of the present study. IL10RA, IL15, IL10 and JAK3 from the Toll-like receptor signaling pathway and CASP1, IL18, IL1B and TRAF6 from the NOD-like receptor signaling pathway, which are important for generating mature proinflammatory cytokines, were also identified in this module and are confirmed by previous studies ([@b35-etm-0-0-5185],[@b46-etm-0-0-5185]). Module B also included the osteoclastogenesis pathway, which is predominantly regulated by signaling pathways activated by immune receptors ([@b47-etm-0-0-5185]).

Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that share a conserved domain structure. MMPs are capable of degrading various types of extracellular matrix (ECM) and serve an important function in tissue remodeling associated with various physiological and pathological processes ([@b48-etm-0-0-5185]). The expression of several MMPs is maximal during the menstrual phase in the human endometrium ([@b49-etm-0-0-5185]). MMPs also have a vital role in the pathogenesis of endometriosis and cancer, particularly in the processes of metastasis and invasion ([@b33-etm-0-0-5185],[@b50-etm-0-0-5185]). MMP1, MMP7, MMP12, MMP13, IGF1, IGFBP1, PAPPA and TIMP2 were identified as the hub genes in module C. ECM-receptor interaction, focal adhesion and proteasomes were also identified in this module, as in previous studies ([@b32-etm-0-0-5185],[@b51-etm-0-0-5185],[@b52-etm-0-0-5185]).

The immune response is one of the major factors influencing pathogenesis of endometriosis. Numerous genes in the fourth module are involved in the function of the immune system. Hub genes in this module are members of the HLA gene family, including HLA-A, -B, -C, -DPB1, -DQA1, -DQB1 and -DRB1, which have key roles in the immune response, and it appears that endometriosis shares many similarities with autoimmune diseases ([@b34-etm-0-0-5185],[@b53-etm-0-0-5185]). It has been demonstrated that patients with endometriosis display a significantly higher expression of HLA I and II molecules compared with individuals without endometriosis ([@b54-etm-0-0-5185]).

Oxidative stress has been proposed as a potential factor involved in the pathophysiology of endometriosis ([@b55-etm-0-0-5185]). Accumulation of reactive oxygen species may induce cellular injury, such as DNA damage. The present study demonstrated that the majority of the pathways in module E were related to replication and repair. APEX1, OGG1, XRCC1, ERCC2 and ERCC5 were the seed genes identified in this module. APEX1 and XRCC1 are key genes involved in the base excision repair pathway, which removes DNA adducts induced predominantly by oxidation and alkylation ([@b56-etm-0-0-5185]). APEX1 is an essential enzyme and has a central role in the DNA repair system; however, a study by Hsu *et al* ([@b57-etm-0-0-5185]) demonstrated that APEX1 Asp148Glu was not associated with endometriosis in patients in Taiwan. Future studies may confirm the association between APEX1 and the risk of endometriosis. XRCC1 has been demonstrated to physically interact with several enzymes known to be involved in the repair of single-strand breaks in DNA ([@b58-etm-0-0-5185]). A study by Hsieh *et al* ([@b36-etm-0-0-5185]) indicated that XRCC1 Arg399Gln polymorphism is correlated with a higher susceptibility to endometriosis.

In conclusion, the pathogenesis of endometriosis is likely multifactorial. The present study constructed a disease network of endometriosis that integrated human protein-protein interactions and known disease-causing genes. The present study has identified a number of biological mechanisms that may be associated with endometriosis. Further studies on the specific function and interactions of the genes in related modules are required to improve the understanding of endometriosis.
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![Known and potential endometriosis biomarkers found by protein-protein interaction. The (A) first and (B) second modules are shown. Red circles represent seed genes and blue/grey circles represent the identified endometriosis biomarker genes, based on the seed genes with blue circles being confirmed by literature and grey circles representing currently unconfirmed biomarker genes.](etm-14-05-4647-g01){#f2-etm-0-0-5185}

###### 

Hub genes in each module.

  Module   Gene ID   Gene symbol
  -------- --------- -------------
  A          196     AHR
  A          367     AR
  A          405     ARNT
  A        2099      ESR1
  A        8204      NRIP1
  A        2100      ESR2
  A        7157      TP53
  A        2516      NR5A1
  A        2908      NR3C1
  A        5241      PGR
  B        3557      IL1RN
  B        3552      IL1A
  B        3554      IL1R1
  B        3553      IL1B
  B        3560      IL2RB
  B        3600      IL15
  B        3565      IL4
  B        3586      IL10
  B        3606      IL18
  C        4316      MMP7
  C        3479      IGF1
  C        3484      IGFBP1
  C        4312      MMP1
  C        5069      PAPPA
  C        7077      TIMP2
  C        4322      MMP13
  C        4321      MMP12
  D        3106      HLA-B
  D        3105      HLA-A
  D        3107      HLA-C
  D        3115      HLA-DPB1
  D        3117      HLA-DQA1
  D        3119      HLA-DQB1
  D        3123      HLA-DRB1
  E          328     APEX1
  E        4968      OGG1
  E        7515      XRCC1
  E        2068      ERCC2
  E        2073      ERCC5
  F          355     FAS
  F          356     FASLG
  F        7132      TNFRSF1A
  F        7124      TNF
  F        4049      LTA

###### 

Top 10 KEGG pathways ranked by P-value for the top six modules in endometriosis.

  Functional modules (no. of genes)   Map title in KEGG                                         No. of genes mapped in the pathway   P-value^[a](#tfn1-etm-0-0-5185){ref-type="table-fn"}^
  ----------------------------------- --------------------------------------------------------- ------------------------------------ -------------------------------------------------------
  Module A (n=42)                     Pathways in cancer (hsa05200)                             7                                    \<0.0001
                                      Thyroid cancer (hsa05216)                                 3                                    \<0.0001
                                      Prostate cancer (hsa05215)                                4                                    0.0001
                                      Oocyte meiosis (hsa04114)                                 4                                    0.0003
                                      Neurotrophin signaling pathway (hsa04722)                 4                                    0.0005
                                      Cell cycle (hsa04110)                                     4                                    0.0005
                                      Basal transcription factors (hsa03022)                    3                                    0.0005
                                      Colorectal cancer (hsa05210)                              3                                    0.0008
                                      Wnt signaling pathway (hsa04310)                          4                                    0.0009
                                      Renal cell carcinoma (hsa05211)                           3                                    0.0011
  Module B (n=54)                     Cytokine-cytokine receptor interaction (hsa04060)         19                                   \<0.0001
                                      Apoptosis (hsa04210)                                      11                                   \<0.0001
                                      JAK-STAT signaling pathway (hsa04630)                     15                                   \<0.0001
                                      Pertussis (hsa05133)                                      9                                    \<0.0001
                                      Measles (hsa05162)                                        11                                   \<0.0001
                                      Tuberculosis (hsa05152)                                   11                                   \<0.0001
                                      Toxoplasmosis (hsa05145)                                  9                                    \<0.0001
                                      Leishmaniasis (hsa05140)                                  7                                    \<0.0001
                                      Intestinal immune network for IgA production (hsa04672)   6                                    \<0.0001
                                      Toll-like receptor signaling pathway (hsa04620)           7                                    \<0.0001
  Module C (n=60)                     Complement and coagulation cascades (hsa04610)            6                                    \<0.0001
                                      Hypertrophic cardiomyopathy (hsa05410)                    4                                    0.0009
                                      ECM-receptor interaction (hsa04512)                       4                                    0.0010
                                      Dilated cardiomyopathy (hsa05414)                         4                                    0.0012
                                      Hematopoietic cell lineage (hsa04640)                     3                                    0.0111
                                      Focal adhesion (hsa04510)                                 4                                    0.0208
                                      Proteasome (hsa03050)                                     2                                    0.0237
                                      Pathways in cancer (hsa05200)                             5                                    0.0280
                                      Vitamin B6 metabolism (hsa00750)                          1                                    0.0316
                                      Staphylococcus aureus infection (hsa05150)                2                                    0.0355
  Module D (n=87)                     Phagosome (hsa04145)                                      17                                   \<0.0001
                                      Cell adhesion molecules (hsa04514)                        24                                   \<0.0001
                                      Antigen processing and presentation (hsa04612)            24                                   \<0.0001
                                      Natural killer cell mediated cytotoxicity (hsa04650)      13                                   \<0.0001
                                      T cell receptor signaling pathway (hsa04660)              18                                   \<0.0001
                                      Intestinal immune network for IgA production (hsa04672)   13                                   \<0.0001
                                      Type I diabetes mellitus (hsa04940)                       17                                   \<0.0001
                                      Leishmaniasis (hsa05140)                                  14                                   \<0.0001
                                      Toxoplasmosis (hsa05145)                                  13                                   \<0.0001
                                      Staphylococcus aureus infection (hsa05150)                13                                   \<0.0001
  Module E (n=87)                     Purine metabolism (hsa00230)                              19                                   \<0.0001
                                      Pyrimidine metabolism (hsa00240)                          19                                   \<0.0001
                                      RNA polymerase (hsa03020)                                 12                                   \<0.0001
                                      DNA replication (hsa03030)                                17                                   \<0.0001
                                      Base excision repair (hsa03410)                           22                                   \<0.0001
                                      Nucleotide excision repair (hsa03420)                     31                                   \<0.0001
                                      Mismatch repair (hsa03430)                                14                                   \<0.0001
                                      Homologous recombination (hsa03440)                       7                                    \<0.0001
                                      Huntington\'s disease (hsa05016)                          13                                   \<0.0001
                                      Basal transcription factors (hsa03022)                    6                                    \<0.0001
  Module F (n=38)                     Cytokine-cytokine receptor interaction (hsa04060)         12                                   \<0.0001
                                      Apoptosis (hsa04210)                                      14                                   \<0.0001
                                      RIG-I-like receptor signaling pathway (hsa04622)          7                                    \<0.0001
                                      Tuberculosis (hsa05152)                                   8                                    \<0.0001
                                      Pathways in cancer (hsa05200)                             10                                   \<0.0001
                                      Natural killer cell mediated cytotoxicity (hsa04650)      7                                    \<0.0001
                                      Chagas disease (American trypanosomiasis; hsa05142)       6                                    \<0.0001
                                      Alzheimer\'s disease (hsa05010)                           7                                    \<0.0001
                                      Osteoclast differentiation (hsa04380)                     6                                    \<0.0001
                                      Type I diabetes mellitus (hsa04940)                       4                                    \<0.0001

According to Fisher\'s exact test. KEGG, Kyoto Encyclopedia of Genes and Genomes; JAK-STAT, Janus kinase-signal transducer and activator of transcription; IgA, immunoglobulin A; ECM, extracellular matrix.

###### 

Details of the 15 potential endometriosis biomarkers in modules A and B demonstrated in literature.

  Gene ID   Gene symbol   Module   PMID       Description
  --------- ------------- -------- ---------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1051      CEBPB         A        23097472   A novel functional link between C/EBPβ and STAT3 that is a critical regulator of endometrial differentiation in women.
  1499      CTNNB1        A        23765252   CTNNB1 mutations are significantly different in low-grade ovarian endometrioid carcinomas (53%) compared with low-grade endometrial endometrioid carcinomas (28%; P\<0.0057).
  2289      FKBP5         A        22279148   No significant endometriosis-related change was observed for FKBP5.
  6908      TBP           A        18252806   TBP inhibits the TNF-α-induced expression of endome triotic genes in 12Z endometriotic epithelial cells.
  10499     NCOA2         A        12050280   Abnormal increases in endometrial TIF2 and SRC-3 levels are also associated with infertility in women with polycystic ovary syndrome.
  6657      SOX2          A        23670619   Samples from endometriosis patients had higher mRNA expression levels of Oct-4, CXCR4, SOX2 and MET compared with that of the normal controls.
  6662      SOX9          A        23847113   Cells in ectopic endometriosis lesions also expressed SSEA-1 and nuclear SOX9.
  2         A2M           B        2454848    Women with endometriosis had significantly lower amounts of functional α-2M than did women without endometriosis.
  836       CASP3         B        24246915   Significantly lower expression of caspase-3 protein was found in ectopic (3.20±1.24) and eutopic endometrium (3.88±1.93) as compared with the control group (6.49±1.85; P\<0.01).
  7189      TRAF6         B        20130413   TRAF2, TRAF6 and TAK1 were constitutively activated and were unaffected by TSA treatment in endometriotic cells.
  834       CASP1         B        17094974   Eutopic and ectopic ECs from women with endome triosis expressed decreased transcript abundance of p53 and Caspase-1 compared to ECs from women without endometriosis.
  6284      S100A13       B        15821778   Expression of S100A13 corresponds to the activation of the endothelial cells in the process of endometriotic angiogenesis.
  7850      IL1R2         B        17482186   IL-1RII can neutralize IL-1β and counteract its effect on endometrial stromal cells, and may provide a new clinical strategy for the treatment of endometriosis.
  3561      IL2RG         B        16759924   IL2RG was demonstrated to be significantly differen tially expressed in blood lymphocytes between endome triosis patients and controls.
  3718      JAK3          B        17631002   JAK3 inhibitors, especially JANEX-1, may prove useful to prevent or alleviate the symptoms of endometriosis.

CEBPB, CCAAT/enhancer binding protein β; CTNNB1, catenin β 1; FKBP5, FK506 binding protein 5; TBP, TATA-box binding protein; NCOA2, nuclear receptor coactivator 2; SOX2, SRY-box 2; SOX9, SRY-box 9; A2M, α-2-macroglobulin; CASP3, caspase 3; TRAF6, TNF receptor associated factor 6; CASP1, caspase 1; S100A13, S100 calcium binding protein A13; IL1R2, interleukin 1 receptor type 2; IL2RG, interleukin 2 receptor subunit gamma; JAK3, Janus kinase 3.
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